Center for Precision Imaging

  • Home

  • About

  • Research

    • Immune System /Tumor Microenvironment
    • Metabolic Imaging
    • Receptor Imaging
    • Interventional Oncology & Devices
    • Clincial Translation
  • Publications

  • Opportunities

  • Contact

  • More

    Use tab to navigate through the menu items.
    Clinical Translation / Trials

    Clinical Translation / Trials

    Design, construction and testing of a low-cost automated 68Gallium-labeling synthesis unit

    Design, construction and testing of a low-cost automated 68Gallium-labeling synthesis unit

    Am J Nucl Med Mol Imaging. 2016; 6(3): 176–184. The interest in 68Gallium labeled PET probes continues to increase around the world....
    Comparison of the clinical performance of upper abdominal PET/DCE-MRI with and without MoCo

    Comparison of the clinical performance of upper abdominal PET/DCE-MRI with and without MoCo

    European Journal of Nuclear Medicine and Molecular Imaging. 2018 Nov;45(12):2147-2154. Purpose: To compare the clinical performance of...

    18 F-Fluciclovine PET in Men With BCR PCa after Prostatectomy and planning for Salvage Radiation

    Pract Radiat Oncol. Sep-Oct 2020;10(5):354-362 Purpose: Conventional imaging rarely localizes the site(s) of prostate cancer recurrence...
    18 F-FES PET/CT Measurement of ER Suppression during a Phase I Trial of GDC-0810

    18 F-FES PET/CT Measurement of ER Suppression during a Phase I Trial of GDC-0810

    Clin Cancer Res; 23(12); 3053-60. Purpose: Evaluate 18F-fluoroestradiol (FES) PET/CT as a biomarker of estrogen receptor (ER) occupancy...
    C11 Methionine PET (MET-PET) Imaging of Glioblastoma for Detecting Postoperative Residual Disease

    C11 Methionine PET (MET-PET) Imaging of Glioblastoma for Detecting Postoperative Residual Disease

    Int J Radiat Oncol Biol Phys. 2018 Nov 15; 102(4): 1024–1028. Purpose: Response criteria of glioblastoma after chemoradiation do not...
    Clinical impact of PET/MR in treated colorectal cancer patients

    Clinical impact of PET/MR in treated colorectal cancer patients

    European Journal of Nuclear Medicine and Molecular Imaging. 2019 Oct;46(11):2260-2269. Purpose: The primary aim of the present study was...
    Management implications of FDG PET/MR in untreated intrahepatic cholangiocarcinoma

    Management implications of FDG PET/MR in untreated intrahepatic cholangiocarcinoma

    European Journal of Nuclear Medicine and Molecular Imaging. 2020 Jul;47(8):1871-1884. Purpose: Intrahepatic cholangiocarcinoma (ICC) is...
    A Phase II Trial of Cabozantinib in Hormone Receptor-Positive Breast Cancer with Bone Metastases

    A Phase II Trial of Cabozantinib in Hormone Receptor-Positive Breast Cancer with Bone Metastases

    Oncologist. 2020 Aug; 25(8): 652–660. Background We assessed the antitumor activity of cabozantinib, a potent multireceptor oral tyrosine...
    Improving staging of rectal cancer in the pelvis: the role of PET/MRI

    Improving staging of rectal cancer in the pelvis: the role of PET/MRI

    European Journal of Nuclear Medicine and Molecular Imaging. 2021 Apr;48(4):1235-1245. Purpose The role of positron emission...
    PET/MRI assessment of lung nodules in primary abdominal malignancies: sensitivity and outcome analys

    PET/MRI assessment of lung nodules in primary abdominal malignancies: sensitivity and outcome analys

    European Journal of Nuclear Medicine and Molecular Imaging. volume 48, pages 1976–1986 (2021) Purpose To evaluate PET/MR lung nodule...
    Evaluation of the Diagnostic Performance of PET/MR for the Diagnosis of Liver Metastases

    Evaluation of the Diagnostic Performance of PET/MR for the Diagnosis of Liver Metastases

    Invest Radiol. 2021 Mar 25. Objective: The aim of this study was to compare the performance of positron emission tomography...
    The Impact of PET with 18F-Fluciclovine on the Treatment of BCR of PCa: Results from the LOCATE Tria

    The Impact of PET with 18F-Fluciclovine on the Treatment of BCR of PCa: Results from the LOCATE Tria

    J Urol. 2019 Feb; 201(2): 322–331. Purpose: The prospective, multicenter LOCATE (F Fluciclovine [FACBC] PET/CT in Patients with Rising...
    Multitargeted TKI produces discordant changes between 99mTc-MDP bone scans and other biomarkers

    Multitargeted TKI produces discordant changes between 99mTc-MDP bone scans and other biomarkers

    J Nucl Med. 2012 Nov; 53(11): 1670–1675. Purpose: One of the central unanswered questions in prostate cancer research is the significance...
    Prospective trial with optical molecular imaging for percutaneous interventions in hepatic lesions

    Prospective trial with optical molecular imaging for percutaneous interventions in hepatic lesions

    Radiology. 2015 Mar;274(3):917-26. Purpose: To demonstrate the clinical translation of optical molecular imaging (OMI) for the...
    Pilot Clinical Trial of Indocyanine Green Fluorescence-Augmented Colonoscopy in High Risk Patients

    Pilot Clinical Trial of Indocyanine Green Fluorescence-Augmented Colonoscopy in High Risk Patients

    Gastroenterol Res Pract. 2016; 2016: 6184842. White light colonoscopy is the current gold standard for early detection and treatment of...
    Performance of fluciclovine PET/MR in the evaluation of osseous metastases from CRPC

    Performance of fluciclovine PET/MR in the evaluation of osseous metastases from CRPC

    Eur J Nucl Med Mol Imaging. 2020 Jan;47(1):105-114. Purpose: 18F-Fluciclovine is indicated for evaluation of suspected prostate cancer...
    Impact of 18F-FDG PET/MR based tumor delineation in radiotherapy planning for cholangiocarcinoma

    Impact of 18F-FDG PET/MR based tumor delineation in radiotherapy planning for cholangiocarcinoma

    Abdom Radiol (NY). 2021 Mar 27. Purpose: Radiation therapy (RT) is an effective treatment for unresectable cholangiocarcinoma (CC)....
    Baseline TLG measured with FDG PET/CT as a predictor of PFS in DLBCL

    Baseline TLG measured with FDG PET/CT as a predictor of PFS in DLBCL

    Am J Nucl Med Mol Imaging. 2013; 3(3): 272–281. This pilot study investigates the value of baseline total lesion glycolysis (TLG) in...
    A phase one, single-dose, open-label, clinical safety and PET/MR imaging study of 68 Ga-DOTATOC

    A phase one, single-dose, open-label, clinical safety and PET/MR imaging study of 68 Ga-DOTATOC

    Am J Nucl Med Mol Imaging. 2017; 7(2): 53–62. This prospective pilot study provides a dynamic whole body PET/MR image database, clinical...

    149, 13th St, Charlestown, MA 02114

    MGH.Precision.Imaging@gmail.com